US Patent Issued to AZURITY PHARMACEUTICALS on Aug. 12 for "Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate" (Indian, American Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,491, issued on Aug. 12, was assigned to AZURITY PHARMACEUTICALS INC. (Woburn, Mass.).

"Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate" was invented by Rahul Dhulaji Bhise (Hyderabad, India), Ajay Kumar Singh (Princeton, N.J.), Mahadeo Vasant Mahadik (Hyderabad, India), Ashish Anilrao Dubewar (Hyderabad, India) and Molugu Prashanth Reddy (Hyderabad, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Stable, ready-to-use injectable pharmaceutical compositions are provided, comprising the combination of neostigmine, glycopyrrolate, and a pharmaceutically acceptable liquid vehicle, optionally with additio...